CHE.496/2008/Projects/1/Patrick Gildea: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 18: | Line 18: | ||
**[[Image:Production of the Antimalarial Drug Precursor Artemisinic Acid.ppt]] | **[[Image:Production of the Antimalarial Drug Precursor Artemisinic Acid.ppt]] | ||
*My Talking notes: | |||
My Talking notes: | **[[Image:Presentation Notes.doc]] | ||
*'''[[User:Patrick Gildea|Patrick Gildea]] 01:26, 13 February 2008 (CST)''': | *'''[[User:Patrick Gildea|Patrick Gildea]] 01:26, 13 February 2008 (CST)''': |
Latest revision as of 06:23, 13 February 2008
Patrick Gildea's Project 1
- I will be presenting a paper on Jay D. Keasling's research on the production of the antimalarial drug precursor
artemisinic acid in engineered yeast.
- This is the specific article that I will be referring to in the presentation:
- [http://www.nature.com/nature/journal/v440/n7086/pdf/nature04640.pdf "Production of the antimalarial drug precursor
artemisinic acid in engineered yeast"]
- (For my fellow team-mates) A very helpful primer on metabolic engineering is available here that is written by the same guy (Keasling) who did the work on Artemisinin, etc.
- My Powerpoint Presentation:
- My Talking notes:
- Patrick Gildea 01:26, 13 February 2008 (CST):